Risperdal litigation
Litigation alleged that the antipsychotic Risperdal caused boys and young men to develop breast tissue, a condition called gynecomastia, without adequate warning.
Free case review
What the litigation alleged
Risperdal elevates prolactin, a hormone that stimulates breast tissue growth. The litigation alleged the manufacturer marketed the drug for use in children before approval and minimized gynecomastia data, leading to verdicts and settlements across thousands of cases.
Injuries named in the litigation
- Gynecomastia in boys and young men
- Corrective surgery (mastectomy)
- Psychological harm
Who may qualify
If you or your son developed gynecomastia after taking Risperdal, particularly when use began as a minor, you may have a claim. The review is free and confidential, and we will give you an honest answer either way. You pay attorney's fees only if we recover for you.
Call (888) 391‑1315 or use the form for a free, confidential review. You pay attorney's fees only if we recover for you.